A B S T R A C T Low-density lipoprotein (LDL) 
INTRODUCTION
The receptor-dependent cellular low-density lipoprotein (LDL)' pathway appears to be important for the degradation of LDL by a mechanism that also provides the cell with an exogenous source of cholesterol for membrane synthesis (1) . The LDL receptor can be finely regulated in response to the requirement of the cell for cholesterol. Thus, when cultured cells are deprived of cholesterol by exposure to a medium containing lipoprotein-deficient serum (LDS), hydroxymethylglutaryl CoA reductase, and cholesterol synthesis are stimulated, and LDL receptor number is increased (2, 3) . Conversely, exposure to LDL or cholesterol in the medium results in suppression of receptor activity (2) and in inhibition of cholesterol synthesis.
Insulin also plays an important role in the regulation of many aspects of cellular lipid and lipoprotein metabolism, including an effect on the LDL receptor (4) . Fatty acid (5) and cholesterol synthesis (5) are stimulated by the presence of insulin in several cell systems, whereas fatty acid mobilization is inhibited by this hormone (6) . Recent observations suggest that insulin also influences cellular lipoprotein metabolism; physiological concentrations result in stimulation of the binding of LDL to its cell surface receptor as well as subsequent internalization and degradation of this lipoprotein (4) . Thus, insulin may play a role in both the turnover ofcirculating LDL and cellular cholesterol metabolism via the LDL pathway.
Insulin potentially could affect several steps in the cellular LDL pathway. The present study was undertaken to elucidate the mechanism by wh-ich insulin ' Abbreviations used in this paper: LDL, low density lipoprotein (d = 1.019-1.063 g/liter); LDS, lipoprotein-deficient serum (d > 1.25 g/liter); PDS, plasma-derived serum; WBS, whole blood serum.
hormone was added at the same time as the change to LDScontaining medium. Although significant effects on LDL degradation previously have been reported by us to occur at physiological concentrations of insulin (10-100 ,uU/ml) (4) , in the present study, unless otherwise stated, a final concentration of 10,000 ,uU insulin/ml was used to maximize and also produce consistent insulin effects. In eight paired experiments in which 100 ,uU/ml insulin was compared with 10,000 ,uU/ml, stimulation of LDL degradation was higher by a mean of <5% with the larger insulin concentration. In all experiments the test dishes containing insulin were compared with control dishes treated identically in all respects except that no insulin was added. The calcium concentration was optimal for measurement of LDL binding to skin fibroblasts (9) , and was the same in the presence and absence of insulin.
Preparation of'251-labeled LDL and LDS. LDL for incubation with cells was isolated from normolipidemic or hypercholesterolemic donors as described (3, 4) . LDL (d = 1.019-1.063) was isolated by sequential preparative ultracentrifugation using either a Beckman L5-65B or L5-50 ultracentrifuge with the 60 Ti rotor (Beckman Instruments, Inc., Fullerton, Calif.). After recentrifugation ofthe LDL once under identical conditions, the protein content was determined by the Lowry method (10), using bovine serum albumin as standard. The LDL was then iodinated with 1251 by the iodine monochloride method as modified for lipoproteins (11) as described (4, 12) . After iodination, the 125I-LDL was dialyzed against 0.1 M NaCl, 0.02 M KI at 4°C. Radioactive LDL was used within 1 wk ofpreparation and was sterilized by passage through a Millipore filter (0.22-,um pore diameter; Millipore Corp., Bedford, Mass.) immediately before use.
LDS was prepared from pooled human serum by ultracentrifugation at d = 1.25 as described (4) . After recentrifugation under identical conditions, the d > 1.25-fraction was extensively dialyzed, initially against 0.15 M NaCl; 1 mM EDTA, and finally against Ringer's solution. The cholesterol content of 10% LDS so prepared ranged between 0.5 and 0.8 ,ug/ml (determined by gas-liquid chromatography).
Measurement of degradation of '251-labeled LDL by fibroblast monolayers. LDL receptor activity was assayed as the amount of '25I-LDL degraded by the cultured cells. This assay was chosen because it measures net accumulation of breakdown products of LDL in the incubation medium with time, and reflects in an integrated and magnified fashion, events occurring at the level of the LDL receptor (13) . Although a small amount of LDL that has been internalized by nonreceptor-mediated processes may also be detected by this assay, this has been shown to be quantitatively insignificant in cells with normal receptors (14) . In 24 h, heat inactivated for 30 min at 56°C, pooled, and filtered.
To prepare PDS (devoid of the potent mitogenic factors derived from platelets), the other half of the specimen was centrifuged at 1,000 g for 15 min at 40C. The plasma was carefully removed to avoid pipetting off any of the leukocyte and platelet layer. The plasma was then respuln in prechilled tubes at 15,000 g for 30 min at 4°C to remove any residual cells. The supernate was then clotted by incubating with CaCl2 (final concentration 20 ,umol/ml) for 2 h at 37°C. After recentrifugation at 15,000 g at 4°C for 30 min, the PDS was pooled, dialyzed against Tris-HCl, and then chromatographed on a carboxymethyl cellulose column to remove any residual platelet factor. The PDS so prepared was pretested to ensure adequate removal of mitogenic activity (18) .
Measurements of proliferative response to insulin in PDS and WBS. Cells were grown to confluence in 10% pooled human serum. The medium was then changed to either 10% WBS or matched PDS for 48 h. This medium was then removed and replaced by 10% LDS, prepared from the serum (either PDS or WBS) to which the cells had previously been exposed. After (19) .
RESULTS
Stimulation of LDL degradation by insulin appeared to be independent of the glucose concentration of the medium throughout the range tested. At glucose concentrations ranging from 15 to 600 mg/dl, insulin resulted in equal enhancement of LDL degradation ( Fig. 1) . In a separate experiment, complete omission of glucose from the medium had no further effect. Cell number was the same in the presence and absence of added insulin. To exclude the possibility that insulin was binding directly to '25I-LDL, thereby modifying its charge and promoting receptor independent internalization, cells which had not been exposed to insulin previously, were exposed either to regular 125I-LDL or to 125I-LDL which had been preincubated with insulin. LDL binding at 4°C (at which temperature internalization does not occur) was measured; no enhanced binding was observed with 125I-LDL preincubated with insulin. Further confirmation that insulin was enhancing LDL degradation via the LDL receptor and the LDL pathway was obtained by determining LDL degradation in two normal fibroblast strains and in two strains of receptor negative fibroblasts. Whereas in the normal fibroblast controls, degradation of LDL was greater in the presence of insulin (62 and 37%, respectively), the absolute level of LDL degradation by receptor negative cells was extremely low and was not stimulated by insulin (Table I ).
In the experiments described above, cells were preincubated with LDS and insulin for 24 h before the addition of 1251-LDL. Insulin was also present in the medium for the duration of the incubation with labeled lipoprotein. To determine whether shorter periods of exposure to insulin would also influence the LDL receptor, an experiment was performed in which cells were exposed to insulin for brief intervals before the (3, 20) , when the medium is changed from one containing pooled human serum to another containing LDS, there appears to be an acute induction of LDL binding (Fig. 2 ). After reaching a peak at 3 h, binding falls by 6 h, after which it again increases. In the presence of insulin, enhanced binding relative to the non-insulin controls was observed as early as 2 h and remained present throughout the 24 h ofthe experiment (Fig. 2) . To determine whether insulin influenced the rate of stimulation of receptor activity, LDL receptors were initially suppressed by exposure to 10% whole pooled human serum. The cells were then washed and exposed to 10% LDS serum in the presence and absence of insulin. 125I-LDL was added at intervals thereafter for the determination of LDL degradation. The rate ofincrease of LDL degradation on exposure of cells to LDS was greater in the presence ofinsulin than when the hormone was absent from the incubation medium (Fig. 3) . Thus, insulin appears to enhance the rate of receptor expression during exposure of cells to a cholesterol-deprived medium.
To evaluate whether insulin-induced stimulation of LDL receptor activity was caused by an increased affinity of LDL for its receptor or caused by an increase in the number of available receptors, LDL concentration curves were compared in the presence and absence of insulin using LDL degradation as an assay of receptor activity. Increasing the amount of added 125I1 LDL resulted in saturation of LDL receptor activity both in the presence and absence of insulin (Fig. 4A) . At all concentrations of added LDL, receptor activity was greater in the presence of insulin. Linearization techniques (21) were employed to calculate the apparent Km and Vmax of LDL receptor activity (Fig. 4B) . The major effect of insulin was to increase the apparent Vmax from 2.91 to 4.44 4g/106 cells/24 h, while no difference between apparent Km was observed in the presence and absence of insulin (9 and 8 ,g/ml LDL protein, respectively).
To exclude the possibility that the increased receptor activity in the presence of insulin was caused by an effect of the hormone on the rate of degradation of the LDL receptor itself, an experiment was performed in which the rate of loss of receptor activity was measured in the presence and absence of insulin. Receptor FIGURE 3 Effect of time of exposure to LDS on insulininduced inhancement of LDL degradation. Cells were grown to confluence in 10% pooled human serum. At time zero the medium was changed to 10% LDS with (0) or without (0) insulin (10,000 uU/ml). 7.5 ,ug/ml 1251-LDL (250 cpm/ng) was added at the times indicated for determination of LDL degradation over the ensuing 4 h. presence and absence of insulin, LDL binding activity decreased with increasing time of exposure to cycloheximide. Exposure to insulin did not influence the rate of decline of LDL receptor activity, which had half-lives of 79 and 71 h in the presence and absence of insulin, respectively. A series of experiments was then performed to evaluate whether insulin-induced changes in cellular cholesterol metabolism could possibly account for the changes observed in LDL degradation and LDL receptor activity. The effect of insulin on the egress of cholesterol from cells was studied by prelabeling confluent fibroblasts with [3H]cholesterol for 48 h, by which time it was assumed that [3H]cholesterol had equilibrated with cellular cholesterol. The cells were then washed and the medium was changed to one containing 10% LDS for the determination of appearance of [3H]cholesterol in the medium over the ensuing 24 h. During this time period, the presence of insulin in the medium failed to result in any detectable difference in the egress of [3HJcholesterol (Fig. 5) . Insulin at both 100 and 10,000 ,uU/ml also did not influence the increase in cholesterol content of LDS after 24 h exposure to cells (Table IIA) . The effect of insulin on cholesterol synthesis was also evaluated. To stimulate cholesterol synthesis, cells were grown to confluence in 10% whole pooled human serum and then deprived of a source of exogenous cholesterol supply by a change of the medium to 10% LDS. Cholesterol synthesis was evaluated by pulse labeling with [14C]acetate after 4, 24, 48, and 72 h exposure to LDS with or without insulin. Depriving the cells of exogenous cholesterol resulted in a time-related increase in cholesterol synthesis; the presence of insulin resulted in approximately a threefold magnification of these changes by 72 h (Fig.  6 ). The addition of insulin in medium containing LDS did not increase cell total cholesterol content despite simultaneous stimulation of LDL binding (Table II) . Cellular content of unesterified cholesterol showed a slight but statistically insignificant increase in the presence of insulin (Table IIB ).
All the experiments described thus far were performed with cells that had been deprived of exogenous cholesterol. To determine whether insulin stimulated LDL degradation under circumstances where cells were not cholesterol depleted, an experiment was performed in which cells were exposed to one of four test media (in the presence and absence of insulin) for 24 h before the addition of 125I-LDL. Cells exposed for 24 h to 10% LDS acted as cholesterol-deprived controls. To suppress LDL receptor activity, cells were exposed for 24 h to either 10% pooled human serum or 25-hydroxycholesterol (2 gg/ml) and cholesterol (20 jig/ml) dissolved in 10 ,ul ethanol. A further set ofcontrols had 10 resulted in a reduction of LDL degradation compared to cells exposed to 10% LDS (Table III) 24 h, 125I-LDL was added for determination of its degradation. An inverse relationship between LDL degradation and cell density was observed (Fig. 7A) . Insulin did not enhance LDL degradation when the final cell density was <105 cells per dish. At higher cell numbers insulin enhanced LDL degradation by 10% at 1.5 x 105 cells, 22% at 5.1 x 105, and 30% at 9.4 x 105 cells (Fig. 7A) . In the second experiment, an equal number of cells (i.e., 2 x 105/dish) were plated into replicate 35-, 60-, and 90-mm diameter dishes and the same protocol followed Hours of Exposure to LDS FIGURE 6 Effect of insulin on sterol synthesis by cultured cells. Cells were grown to confluence in 10% pooled human serum. After washing the cell layer, the medium was changed to 10% LDS with (0) or without (0) insulin (10,000 A.U/ml).
At the times indicated the cells were pulsed with [ 
DISCUSSION
Results in this study confirm and extend the finding that insulin enhances the degradation of LDL by cultured human skin fibroblasts (4) and provides support for a possible mechanism. We have previously reported that insulin stimulated LDL degradation and binding in a dose-dependent fashion within the physiological range of circulating insulin levels (10-100 ,uU/ml). Furthermore, LDL binding, uptake, and degradation were stimulated concurrently and to a similar extent by insulin (4) . Therefore, it is unlikely that the primary effect of insulin on LDL degradation is caused by stimulation of lysosomal enzymes. Were this the case, then expansion of the intracellular regulatory pool of unesterified cholesterol (resulting from hydrolysis of LDL The same number of cells (i.e., 2 x 105) were plated into different-sized dishes to achieve different degrees of cell density (0= insulin (10,000 ,uU/ml); 0 = no added insulin). In both experiments the amount of LDL degraded was inversely related to the cell density in the dish. Also, insulin resulted in greater stimulation of LDL degradation in dishes in which cells were cholesterol esters) would be expected to inhibit rather than stimulate the LDL receptor (2, 3) . Further, in the absence of the LDL receptor, no insulin-induced enhancement of degradation was observed. Thus, insulin appears to enhance LDL degradation by stimulation of the receptor-dependent LDL pathway. Because LDL degradation was equally stimulated by insulin throughout the glucose concentration range tested and because no further effect was observed in glucose-free medium, this suggests that these changes are independent of an effect of insulin on glucose transport. Although most of these studies were performed at supraphysiological concentrations of insulin (10,000 ,uU/ml), previous studies from our laboratory have shown little additional effect on LDL degradation of this concentration when compared with a more physiological concentration (100 ,uU/ml) (4) . Also, where both 100 and 10,000 ,U/ml were used in the same experiment, very similar effects resulted (Table II) .
Analysis of LDL concentration curves shows that LDL receptor activity is saturable both in the presence and absence of insulin, but that receptor activity in the presence of insulin is greater at all concentrations of LDL. The major effect of insulin appears to be an increase in apparent Vmax without a change in apparent Km. These findings strongly support the notion that insulin increases the number of LDL receptors rather than alters the affinity of the lipoprotein for its cell surface receptor or induces a second LDL receptor of differing affinity. The similar half-lives of receptor activity after cycloheximide treatment suggests that the effects of insulin on the LDL receptor cannot be explained by a change in the rate of degradation of the LDL receptor itself. The stimulation of LDL binding by insulin was rapid, occurring as early as after 2 h of exposure to insulin, suggesting that receptor synthesis is rapidly induced.
Regulation of the LDL receptor in vitro is achieved to a large extent by factors which influence the availability of cellular cholesterol (2) . Thus, deprivation of exogenous cholesterol supply by exposure of cells to lipoprotein-deficient serum results in an increase in LDL receptor activity (2, 3) presumably by altering the intracellular regulatory pool of unesterified cholesterol (1). Conversely, abundant availability of cholesterol either as LDL (2, 3) or as oxygenated cholesterol derivatives (23) results in down regulation of the LDL receptor. Conditions that deplete this putative regulatory pool of unesterified cholesterol, in addition to stimulating the LDL receptor, also result in stimulation of endogenous cholesterol synthesis (1). It is possible that insulin acts by influencing this cellular cholesterol pool. Previously, insulin has been shown to stimulate cholesterol synthesis by cultured cells by enhancing hydroxymethylglutaryl CoA reductase activity in serum-free medium (5 (Table III) . Despite the lack ofeffect ofinsulin on cholesterol egress, and despite simultaneous stimulation of LDL receptor activity (Table II) and enhanced cholesterol synthesis occurring under identical conditions, cells exposed to insulin in LDS did not accumulate significantly more cholesterol than those not exposed to the hormone. Presumably this is partly the result of incubation of the cells in LDS, which is essentially devoid of LDL. Thus, the only LDL available for internalization is the radioactive tracer. Further, any extra cholesterol made available by stimulation ofendogenous synthesis would be small when compared against a high background ofcell membrane cholesterol and hence undetectable by the methodology used.
Since a well known effect ofinsulin is the stimulation of cellular growth and proliferation (22) , potential enhancement ofboth exogenous (via the LDL pathway) and endogenous cholesterol supply (via endogenous synthesis) by the hormone could provide the additional cholesterol required for new membrane synthesis. However, under the conditions of these experiments using high cell density and short-term exposure to the hormone, insulin did not stimulate either cell number or cellular protein content (data not shown). Also, neither cell number nor the extent of stimulation of LDL degradation were increased by insulin at lower cell densities. Therefore, to test whether the stimulation of LDL degradation by insulin merely reflected an increased cellular turnover not detectable by changes in cell number or protein content, an experiment was designed in which the effect of insulin on LDL degradation was compared under conditions of quiescence and active DNA synthesis. Quiescence without serum starvation was achieved by incubation of a confluent cell monolayer with PDS devoid of the potent mitogenic platelet factor (18) . Active proliferation was maintained by using matched WBS prepared in such a way as to preserve platelet factor activity. The medium was then changed to LDS from either PDS or WBS to stimulate LDL receptor activity. Despite the marked disparity in DNA synthetic response to insulin between cells exposed to PDS and WBS, LDL degradation was stimulated to a similar degree nonetheless. Cell number was not influenced by insulin, presumably because of the lack of cholesterol in the incubation medium. Thus, neither DNA synthesis nor cellular proliferation appears to be a prerequisite for insulin-induced stimulation of LDL degradation and the findings observed cannot merely be attributed to stimulation of the cell cycle. Furthermore, in the experiments to test the effect of cell density on insulin-mediated stimulation of LDL receptor activity, less stimulation of LDL degradation was observed in sparse cultures than in confluent (and hence density-dependent inhibited cells). The most likely explanation for these observations relates to the inverse relationship between LDL receptor activity and cell density observed in the present study and by others (24) (25) (26) . It is possible that high basal levels of LDL receptor activity in sparse cultures may represent maximum or near maximum receptor availability. In that case, little further stimulation of LDL receptor activity would be possible. More confluent dishes, with lower basal LDL receptor activity, would then have greater potential for stimulation of receptor number.
Thus, insulin appears to be capable of enhancing the supply of cholesterol to cells by stimulating both endogenous synthesis and also by stimulating LDL transport via the LDL receptor. The increased cholesterol potentially made available as a result of these two processes could, under appropriate conditions, presumably be used during times of cholesterol deprivation or during times of active cellular growth and proliferation. Enhanced lysosomal degradation of LDL usually accompanies stimulation of LDL binding and stimulation of cholesterol synthesis (1) . Therefore insulin may have a dual role in cellular lipid and lipoprotein metabolism. On the one hand, insulin theoretically could increase the availability of cellular cholesterol, while on the other it stimulates the physiological pathway of LDL degradation in vitro. Since LDL degradation in vivo is believed to be mediated largely via this receptor-mediated pathway, it is conceivable that changes in circulating insulin levels could also modulate LDL degradation in vivo if fibroblasts are a valid model for peripheral LDL degradation. This possibility remains to be tested.
